Environmental poisoning is most commonly associated with chronic longt
erm exposure to toxins rather than to acute exposure. Such repeated ex
posure to sublethal doses of compounds and elements presents problems
in risk assessment. This is primarily because the data are unavailable
to describe relationships between dose and effect at lower levels of
exposure to toxins. Bioavailability of toxins also presents a problem
because the data on bioavailability are sparse and seldom as high as t
he default of 100% bioavailability commonly used in risk assessment. E
xamples are presented of two toxins: arsenic as an elemental anthropog
enic and geologic poison and ciguatoxin, a polyether ladder compound,
as a toxin produced naturally by dinoflagellates. Bioavailability driv
es the toxicity of arsenic from contaminated sites, whereas tissue acc
umulation drives the toxicity of ciguatoxin. Considerable benefit is d
erived from the harmonization of regulatory processes where there is l
inkage of health and environmental factors in the derivation of credib
le risk assessment.